Discovery of Highly Potent Phthalazinone Derivatives as PARP14 Inhibitors: From Structure-Based Virtual Screening to <i>In Vivo</i> Pharmacodynamic ActivityAuthorsJ LiuYi Zou (ORCID: https://orcid.org/0000-0001-6782-9380)Qinlong XuQihua Zhu (ORCID: https://orcid.org/0000-0003-4314-4226)Zhaoxing Chu (ORCID: https://orcid.org/0000-0003-3347-7449)Shiqi WuHongfeng Gu (ORCID: https://orcid.org/0009-0004-4385-3430)Kaiyuan CongZiyue LiGuangwei HeYan ZhaoPing WeiShaoxue LouXiangying KongLi ShaoYungen Xu (ORCID: https://orcid.org/0000-0001-6586-8482)Le QuXiaorong ZengInstitutionsChina Pharmaceutical University (CN)Hefei Design and Research Institute of Coal Industry (China) (CN)State Key Laboratory of Natural MedicinePublication DetailsJournalJournal of Medicinal ChemistryPublished2026-04-20DOIhttps://doi.org/10.1021/acs.jmedchem.6c00004Primary TopicPARP inhibition in cancer therapyTypearticleField-Weighted Citation Impact0.00Explore the Global Research Space Interactive Map